Overview
Marito Araki practices in Tokyo, Japan. Araki is rated as a Distinguished expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Their top areas of expertise are Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Myelofibrosis, and Polycythemia Vera.
Their clinical research consists of co-authoring 59 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 16 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Essential ThrombocythemiaAraki isDistinguished. Learn about Essential Thrombocythemia.
- Myeloproliferative Neoplasms (MPN)
- Advanced
- Blood ClotsAraki isAdvanced. Learn about Blood Clots.
- MyelofibrosisAraki isAdvanced. Learn about Myelofibrosis.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Polycythemia VeraAraki isAdvanced. Learn about Polycythemia Vera.
- Experienced
- Acute Erythroid Leukemia (AEL)
- Acute Megakaryoblastic Leukemia
- Acute Myeloid Leukemia (AML)Araki isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaAraki isExperienced. Learn about Acute Promyelocytic Leukemia.
- Cerebral HypoxiaAraki isExperienced. Learn about Cerebral Hypoxia.
- Chronic Myelogenous Leukemia (CML)